Gestational diabetes secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Following delivery, mothers diagnosed with GDM should have close follow ups to prevent overt diabetes in future. Testing with 75 g OGTT 6 to 12 weeks after delivery, and then every 1-3 years is recommended for early diagnosis of diabetes. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
*The OGTT is recommended over A1C at the 6 to 12 week postpartum visit because A1C may be persistently impacted (lowered) by the increased red blood cell turnover related to pregnancy or blood loss at delivery. | *The OGTT is recommended over A1C at the 6 to 12 week postpartum visit because A1C may be persistently impacted (lowered) by the increased red blood cell turnover related to pregnancy or blood loss at delivery. | ||
* | *GDM is associated with increased maternal risk for diabetes. Following delivery, women should be tested every 1–3 years ( if a 6 to 12 week 75-g OGTT is normal), with the frequency of screening depending on other risk factors such as family history of DM, prepregnancy BMI, and need for insulin or oral glucose lowering medications during pregnancy. | ||
* | *Continuous screening may also be performed with any recommended glycemic test (e.g., hemoglobin A1C, fasting plasma glucose, or 75-g OGTT using nonpregnant thresholds).<ref name="pmid12351492">{{cite journal |vauthors=Kim C, Newton KM, Knopp RH |title=Gestational diabetes and the incidence of type 2 diabetes: a systematic review |journal=Diabetes Care |volume=25 |issue=10 |pages=1862–8 |year=2002 |pmid=12351492 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
| Line 18: | Line 18: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
Latest revision as of 17:36, 10 April 2017
|
Gestational diabetes Microchapters |
|
Complications |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gestational diabetes secondary prevention On the Web |
|
American Roentgen Ray Society Images of Gestational diabetes secondary prevention |
|
Risk calculators and risk factors for Gestational diabetes secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Following delivery, mothers diagnosed with GDM should have close follow ups to prevent overt diabetes in future. Testing with 75 g OGTT 6 to 12 weeks after delivery, and then every 1-3 years is recommended for early diagnosis of diabetes.
Secondary Prevention
- The OGTT is recommended over A1C at the 6 to 12 week postpartum visit because A1C may be persistently impacted (lowered) by the increased red blood cell turnover related to pregnancy or blood loss at delivery.
- GDM is associated with increased maternal risk for diabetes. Following delivery, women should be tested every 1–3 years ( if a 6 to 12 week 75-g OGTT is normal), with the frequency of screening depending on other risk factors such as family history of DM, prepregnancy BMI, and need for insulin or oral glucose lowering medications during pregnancy.
- Continuous screening may also be performed with any recommended glycemic test (e.g., hemoglobin A1C, fasting plasma glucose, or 75-g OGTT using nonpregnant thresholds).[1]